bpc 157 clinicaltrials gov nct Frontiers tm267368d1_6kimg023.jpg

The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use

Before starting any new supplement, always consult a doctor to ensure its safe and suitable for your body

All of them share the same caveats: prescription level, supervision required, and off limits for tested competition

By integrating this IV add-on, our holistic approach aims to fortify the bodys natural defenses, contributing to overall resilience against external stressors